Navigation Links
Cystic Fibrosis - Axentis Pharma Takes Over Patents and Continues Development of Innovative Platform Technology
Date:6/26/2008

ZURICH, Switzerland, June 26 /PRNewswire/ -- The rights to key patents for an innovative screening tool for treatments for cystic fibrosis were transferred today to Swiss biotech company Axentis Pharma AG. The company has acquired the rights from an Austrian firm that has made a vital contribution to the development of new approaches to treating the disease. The core element of the platform technology involves human proteins which - despite offering sufficient functionality - are subjected to enzymatic digestion in untreated cells due to genetic mutations in their structure.

Axentis Pharma AG (Switzerland) today announced that, as part of its takeover of an Austrian research company, it has also acquired two patent families that incorporate a series of international patent applications. The company is taking over these rights from Austrian-based BioDevelops Pharma GmbH, which three years ago identified the therapeutic potential offered by a new approach to the treatment of cystic fibrosis and secured the relevant rights.

The technology directly targets the functional cause of cystic fibrosis - the process whereby the body destroys mutated proteins which were originally designed to regulate the concentration of salt in the epithelial cells of the lungs and other organs. In patients with cystic fibrosis, a genetic defect means that many such proteins are produced with minor structural mutations. Although the mutated proteins still offer sufficient functionality, they are eliminated by quality control functions in the endoplasmic reticulum of the cells. The therapeutic approach now under development at Axentis Pharma enables these proteins - which are still functional despite their mutated structures - to escape enzymatic digestion.

Dr. Gergely Lukacs who guided the experimental set-up in his labs at the Sick Kids Hospital in Toronto explains: "In patients with cystic fibrosis, the protein CFTR (cystic fibrosis conductance regulator) with mu
'/>"/>

SOURCE Axentis Pharma AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cystic Fibrosis Trial In Children Returns Positive Data
2. Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients
3. Genetic manipulation might model cystic fibrosis
4. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
5. Data show a decline in cystic fibrosis since introduction of prenatal carrier screening
6. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
7. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
8. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
9. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
10. Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
11. Wyeth Pharmaceuticals Announces Organizational Change

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...EGO, Nov. 24, 2009 Arena... today that the company is scheduled to present a...ence on December 1, 2009 at 11:30 a.m. Eastern Tim...Hotel in New York City. Jack Lief, Arena,s Preside...ovide an overview of the company, including its cl...
(Date:11/24/2009)...EN, Italy, November 24 Health Robo...dian joint venture with a group of selected,invest...ll operate under the,name Health Robotics Canada, ...Robotics, i.v. Room of the Future concept, which i...ATION(TM), i.v.SOFT(TM), and OMM(TM).,Health Robot...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the global e...s patent office is now the world,s leading produce...hina trailed Japan,s patent office, the World Inte...ted States Patent and Trademark Office (USPTO) for... WIPO in 2006, and exceeded Japan for the first ti...
(Date:11/23/2009).... 23, 2009 In a provocative new study, a Universi...xide emissions the major cause of global warming ...ollapses or society builds the equivalent of one n...likely that there will be any substantial near-ter... carbon dioxide emission rates," says the new pape...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...uled for Wednesday, May 7th at 9:30am EDT, NEW YO... KERX ) today announced that Michael S. Weiss, the...s scheduled to present at the,Deutsche Bank 33rd A...tts., Mr. Weiss, presentation, which will take pl...ebcast live and will be accessible from the Invest...
...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... Annual and Special Meeting,of the Shareholders wi...(ET) at the Yale Club of New York City, 50 Vanderb...n of the meeting, Dr. Brad Thompson,President and ... developing,REOLYSIN(R) as a potential cancer ther...
... Thursday, May 8, 2008, at,8:30 a.m. Eastern/2:30 ...,Cell Therapeutics, Inc.,s (CTI) (Nasdaq: CTIC ; ...nce call to discuss the company,s 2008 first,quart...ce Call Numbers Thursday, May 8 8:30 a.m. Easter...e 1-877-835-3295 (US Participants) 1-303-262-213...
Other Biology Technology:Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference 2Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting 2
(Date:11/24/2009)...to understanding how sounds associated with Navy s...or if they hear it at all. , The same type of la... to detect flaws in the space shuttle,s behemoth s...ek inside the giant head of a whale. The scans are...a whale,s hearing anatomy using a breakthrough met...
(Date:11/24/2009)...ble class of ring-shaped protein motors has been u... National Laboratory (Berkeley Lab) using a state-... Advanced Light Source (ALS). These protein motors...tion, and are vital to the survival of all biologi...he human papillomavirus, which has been linked to ...
(Date:11/24/2009)...eld secrets of the earth,s history locked in its i... little information on the environments that have ...ears. Now, a team of researchers from nine institu... of $10 million dollars by the National Science Fo...literally. These scientists will drill through the...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Unprecedented Scale Up of Voluntary Male Circumcision Begins in Swaziland and Zambia 48558 1Unprecedented Scale Up of Voluntary Male Circumcision Begins in Swaziland and Zambia 48558 2Cord Blood America Continuing European Expansion 48557 1Cord Blood America Continuing European Expansion 48557 2A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2
...rsity study of fruit flies that may revolutionize ...he genes affected by a widely-prescribed drug know... popular cancer-fighting drug also used to treat p...s, and lupus, lasts a long time in the body and ca... it in their systems. The study of the drug,s effe...
... scientists have shown that the amount of health-l...g influences the toasty aroma developed by oats an...vors in oat products. , Polyphenols are a large fa...have been associated with a wide variety of health...ng to the polyphenol family and have been shown to...
... scientists have shown that the amount of health-l...g influences the toasty aroma developed by oats an...vors in oat products. , Polyphenols are a large fa...have been associated with a wide variety of health...ng to the polyphenol family and have been shown to...
Other Biology News:Fruit fly research set to revolutionize study of birth defects 2Chemical compound inhibits tumor growth, size in new mouse study 2Chemical compound inhibits tumor growth, size in new mouse study 3Toasty oat aroma influenced by presence of health-linked polyphenols 2Toasty oat aroma influenced by presence of health-linked polyphenols 3
Bacterial Cell Paste Production Services from ARVYS Proteins, Inc.
Cell biology services from Novascreen-a Caliper Life Sciences Company
Conditioned Media Production Services from ARVYS Proteins, Inc.
...normalization is essential for hunting and analyzi...oaches, such as EST sequencing projects, microarra...methods are not well suited for the normalization ...specially developed for normalization of cDNA enri...
Biology Products: